Scarica l'app Stockscreener
0.8967
2.01%
0.0177
Dopo l'orario di chiusura:
.90
0.0033
+0.37%
Precedente Chiudi:
$0.879
Aprire:
$0.86
Volume 24 ore:
3.33M
Relative Volume:
0.45
Capitalizzazione di mercato:
$161.48M
Reddito:
$850.00K
Utile/perdita netta:
$-68.17M
Rapporto P/E:
-2.1786
EPS:
-0.4116
Flusso di cassa netto:
$-53.29M
1 W Prestazione:
-8.82%
1M Prestazione:
-51.53%
6M Prestazione:
-84.67%
1 anno Prestazione:
-81.20%
Intervallo 1D:
$0.8504
$0.9046
Intervallo di 1 settimana:
$0.8217
$0.99
Portata 52W:
$0.8217
$6.88
Compass Therapeutics Inc Stock (CMPX) Company Profile
Nome
Compass Therapeutics Inc
Settore
Industria
Telefono
617-500-8099
Indirizzo
80 GUEST STREET, BOSTON
Compare CMPX vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
0.8967 | 161.48M | 850.00K | -68.17M | -53.29M | -0.4116 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-23 | Downgrade | Wedbush | Outperform → Neutral |
| 2026-07-01 | Ripresa | Ladenburg Thalmann | Buy |
| 2026-04-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-02-13 | Iniziato | Craig Hallum | Buy |
| 2026-01-05 | Iniziato | William Blair | Outperform |
| 2025-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2025-12-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-12-03 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-07-01 | Ripresa | Raymond James | Outperform |
| 2025-04-02 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Iniziato | Guggenheim | Buy |
| 2025-02-19 | Iniziato | Piper Sandler | Overweight |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Iniziato | Jefferies | Buy |
| 2023-01-27 | Iniziato | Stifel | Buy |
| 2022-05-23 | Ripresa | H.C. Wainwright | Buy |
| 2022-03-15 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-01-19 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Raymond James | Outperform |
| 2021-12-20 | Iniziato | SVB Leerink | Outperform |
| 2021-12-15 | Iniziato | Wedbush | Outperform |
Mostra tutto
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Top insider buys and sells disclosed on Friday - Investing.com
Form 4 Compass Therapeutics, Inc. For: 2 October By Investing.com - Investing.com Australia
Form 4 Compass Therapeutics, Inc. For: 2 October By Investing.com - Investing.com Nigeria
Form 4 Compass Therapeutics, Inc. For: 2 October By Investing.com - Investing.com South Africa
Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares - Investing.com
Form 4 Compass Therapeutics, Inc. For: 2 October - Investing.com India
Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares By Investing.com - Investing.com Canada
Compass Therapeutics CAO Neil Lerner Purchases 20,000 Shares in Open Market Transaction - Kalkine Media
At $0.92 a share, Compass Therapeutics (CMPX) accounting chief buys 20,000 shares. - Stock Titan
Compass Therapeutics (CMPX) Insider Buy: Chief Accounting Officer Neil Lerner Purchases 2,500 Shares - GuruFocus
Form 4 Compass Therapeutics, Inc. For: 25 September By Investing.com - Investing.com Nigeria
Is Compass Therapeutics, Inc. (CMPX) the Healthcare Stocks Stock Everyone's About to Talk About? - Kalkine Media
Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares - Investing.com
Form 4 Compass Therapeutics, Inc. For: 25 September - Investing.com India
Form 4 Compass Therapeutics, Inc. For: 25 September By Investing.com - Investing.com UK
Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares By Investing.com - Investing.com Canada
After buying 2,500 shares, Compass Therapeutics (CMPX) accounting chief reports a 400,000-share position - Stock Titan
How Does FDA Feedback Change the Tovecimig Path for Compass Therapeutics (NASDAQ:CMPX)? - Kalkine Media
Compass Therapeutics Craters, FDA Pushes Survival-Trial Demand for Cancer Drug - tradingview.com
Why Did Compass Therapeutics Stock Plunge Today?Compass Therapeutics (NASDAQ:CMPX) - Benzinga
Form 8K Compass Therapeutics, Inc. For: 22 September By Investing.com - Investing.com India
Compass Therapeutics (Nasdaq:CMPX)Stock Analysis - simplywall.st
CCORF Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Compass (CMPX) Earnings Update: The EPS Result Is Below Expectation in the Current Update; After Earnings: Shares Finish 0.21% Higher on the DayProfit Cycle Analysis - vinanet.vn
Compass (CMPX) Session: Finishes 4.23% Lower at $2.38; Technical Setup: the Supplied Trading Band Runs From $2.26 to $2.50 in the Current UpdateDollar Neutral Pair - vinanet.vn
NEXTBio Capital Management LP's Compass Therapeutics Inc(CMPX) Holding History - GuruFocus
Compass (CMPX) Earnings Data Review: The EPS Result Is Below Expectation in the Available Record; Investor Response: Shares Close 3.46% Higher in the Latest SessionCore Business Growth - vinanet.vn
Compass Therapeutics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Stifel Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st
Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st
Compass Therapeutics Inc. (CMPX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
We're Not Very Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Rate - Moomoo
Compass Therapeutics (CMPX) Climbs 3.26% to $2.22, Approaches Key ResistanceCovered Call Trade - vinanet.vn
HC Wainwright Issues Pessimistic Estimate for CMPX Earnings - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Posts Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Compass Therapeutics Inc. (CMPX) Stock News Today - TradingKey
Compass Therapeutics Inc. (CMPX) Stock News Today - TradingKey
A Quick Look at Today's Ratings for Compass Therapeutics(CMPX.US), With a Forecast Between $6 to $7 - Moomoo
Compass Therapeutics (NASDAQ:CMPX) Price Target Raised to $6.00 at Piper Sandler - MarketBeat
Compass Therapeutics Inc. (CMPX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
State Street (CMPX holder) reports 9.95M Compass Therapeutics shares on Schedule 13G - Stock Titan
Compass Therapeutics, Inc. Stock 12‑Month Price Target Raised to $8.67, Implies 359% Upside - TradingView
Compass Therapeutics, Inc. Q2 2026 Financial Results: Balance Sheet, Losses & Key Highlights from CMPX 10-Q Filing - Minichart
Form 8K Compass Therapeutics, Inc. For: 6 August By Investing.com - Investing.com Nigeria
Compass Therapeutics, Inc. 2026: Revenue ($25.25M), Net income ($25.15M), EPS ($0.13) — 10-Q Summary - tradingview.com
Compass Therapeutics (NASDAQ: CMPX) details Q2 loss and BTC trial gains - stocktitan.net
Form 8K Compass Therapeutics, Inc. For: 6 August By Investing.com - Investing.com Canada
Compass Therapeutics Inc Azioni (CMPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Compass Therapeutics Inc Azioni (CMPX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lerner Neil | Chief Accounting Officer |
Sep 24 '26 |
Buy |
1.14 |
2,500 |
2,850 |
400,000 |
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):